4//SEC Filing
Kelly-Croswell Lisa 4
Accession 0001567619-22-014201
CIK 0001305253other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 7:02 PM ET
Size
5.4 KB
Accession
0001567619-22-014201
Insider Transaction Report
Form 4
Kelly-Croswell Lisa
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-18+30,000→ 30,000 totalExercise: $8.13Exp: 2032-07-17→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from July 18, 2022 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001845596
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 7:02 PM ET
- Size
- 5.4 KB